Dental flossing is associated with a lower risk for ischemic and cardioembolic stroke and atrial fibrillation.

In persistent pulmonary hypertension of the newborn (PPHN), illness severity scores have high accuracy and can predict mortality.

Lifetime history of heavy cannabis use is associated with lower brain activation on working memory tasks among young adults.

A risk score derived from CV reactivity to mental stress improves prediction of adverse CV outcomes over traditional CV risk factors in patients with stable coronary artery disease.

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

A blood-based test (Freenome) may provide a new option for colorectal cancer screening in the average-risk US population.

Variability in total cholesterol and low-density lipoprotein cholesterol is associated with dementia and cognitive impairment.

Prehospital measurement of GFAP can rapidly differentiate intracerebral hemorrhage from ischemic stroke and stroke mimics.

The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.

Substantial gaps in COVID-19 vaccination were identified among people who inject drugs in San Francisco, California in 2022.

Neoantigen-targeting PCVs are highly immunogenic in high-risk clear cell RCC and can target key driver mutations and induce antitumor immunity.